Scientists at the University of Missouri discovered that age-related muscle weakness stems from deteriorating communication between nerves and muscles, specifically involving reduced levels of the protein NaV1.4. Researchers demonstrated that partially inhibiting a protein called ClC-1 improved muscle responsiveness to nerve signals in animal models, offering a potential therapeutic path to treat sarcopenia and preserve strength in older adults.